Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.

Portage Biotech unveils new preclinical data on PORT-7, showing strong antitumor effects in mesothelioma and advancing plans for clinical trials.

Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on ...

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...